ARTICLE | Company News
BioPhausia, Meda sales and marketing update
October 11, 2010 7:00 AM UTC
Specialty pharma BioPhausia divested all of its generic OTC products to Meda for SEK190 million ($28 million) in cash. The products include vitamin-C product C-vimin, Novalucol and Novalucid to treat ...